Bio Break: Surprising Innovations in Olfactory Drug Delivery
In this episode of Bio Break, Joris van der Heijden and Nick Allan explore one of the most innovative approaches in drug delivery: olfactory drug delivery. This cutting-edge method targets the olfactory region of the nose, offering a direct pathway to deliver drugs into the brain while bypassing the blood-brain barrier. Unlike traditional intranasal delivery, this highly specialized technique uses neural pathways to achieve precise and effective results.
Nick shares insights from a fascinating project that leverages the olfactory bulb and cribriform plate—a thin, porous structure within the skull—to transport therapeutic agents directly to the brain. These pathways allow drugs to reach the brain without systemic circulation, overcoming the challenges of the blood-brain barrier that typically blocks most substances.
The discussion also delves into the complexity of nasal anatomy, highlighting the natural defenses that prevent substances from entering the brain. Structures like the nasal valve and turbinates serve critical roles in filtering air and protecting the body, but they also pose significant challenges for targeted drug delivery. Through precise engineering and careful design, the device Nick describes achieves a delicate balance of usability and effectiveness, allowing for safe and accurate drug delivery to the olfactory region.
This approach is especially promising for conditions like Alzheimer’s, Parkinson’s, brain tumors, and other neurological diseases that require direct access to the brain for treatment. By bypassing traditional barriers, olfactory drug delivery opens new opportunities for targeted therapies that were previously inaccessible.
This episode is a must-watch for medical device developers, pharmaceutical innovators, and healthcare professionals interested in the latest advancements in drug delivery technology. Gain insights into how precision engineering and biological understanding can come together to solve complex challenges and unlock groundbreaking treatments for patients.
Surprising Innovations in Olfactory Drug Delivery
Related Resources
Connected health devices are multiplying fast. We examine the gap between remote monitoring’s promise and its reality.
Ariana and Mark walk through what separates a clinical prototype from a proof-of-concept build, what determines how much testing and documentation you actually need, and where the regulatory line between significant risk and non-significant risk falls.
In this episode of Bio Break, Nick walks through both patent types after receiving two of his own in the mail, one of each, from the USPTO.
Scott Phillips sits down with Mickey Urdea to examine what actually distinguishes companies that reach commercial outcomes from those that do not.